Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Thomas

Showing results (181-190 of 273) with videos related to

Pageof 28
Sort By:
Proteomics. Clinical Applications|December 8, 2010
Effects of endurance exercise on the urinary proteome analyzed by 2-D PAGE and Orbitrap MSMaxie Kohler, Katja Walpurgis, Andreas Thomas, et al.
NAM Journal|June 29, 2026
A cryopreserved and <i>in vivo-in vitro</i> validated human induced pluripotent stem cell blood-brain barrier model for reliable neurotoxicity assessmentPaul Kurtenbach, Sam Thilmany, Maria Hahn, et al.
Journal of the American Society for Mass Spectrometry|December 17, 2011
Structure elucidation of the diagnostic product ion at m/z 97 derived from androst-4-en-3-one-based steroids by ESI-CID and IRMPD spectroscopyMario Thevis, Simon Beuck, Sebastian Höppner, et al.
Analytical and Bioanalytical Chemistry|December 1, 2009
Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controlsMario Thevis, Ines Möller, Andreas Thomas, et al.
European Journal of Mass Spectrometry (Chichester, England)|July 16, 2016
Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposesAndreas Lagojda, Dirk Kuehne, Oliver Krug, et al.
Analytical and Bioanalytical Chemistry|August 7, 2012
Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometryCornelius Hess, Andreas Thomas, Mario Thevis, et al.
Drug Testing and Analysis|October 11, 2012
Influence of repeated subcutaneous G-CSF injections on selected blood parameters relevant for monitoring programmes in sports drug testingKatja Walpurgis, Mirjana Slijepcevic, Folker Wenzel, et al.
Rapid Communications in Mass Spectrometry : RCM|February 28, 2014
Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysisMario Thevis, Gerd Sigmund, Andreas Thomas, et al.
Analytical and Bioanalytical Chemistry|February 8, 2011
Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometryAndreas Thomas, Sebastian Höppner, Hans Geyer, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 10, 2014
Use of dried blood spots in doping control analysis of anabolic steroid estersLaura Tretzel, Andreas Thomas, Hans Geyer, et al.
Pageof 28

Showing results (181-190 of 273) with videos related to

Sort By:
Pageof 28
Proteomics. Clinical Applications|December 8, 2010
Effects of endurance exercise on the urinary proteome analyzed by 2-D PAGE and Orbitrap MSMaxie Kohler, Katja Walpurgis, Andreas Thomas, et al.
NAM Journal|June 29, 2026
A cryopreserved and <i>in vivo-in vitro</i> validated human induced pluripotent stem cell blood-brain barrier model for reliable neurotoxicity assessmentPaul Kurtenbach, Sam Thilmany, Maria Hahn, et al.
Journal of the American Society for Mass Spectrometry|December 17, 2011
Structure elucidation of the diagnostic product ion at m/z 97 derived from androst-4-en-3-one-based steroids by ESI-CID and IRMPD spectroscopyMario Thevis, Simon Beuck, Sebastian Höppner, et al.
Analytical and Bioanalytical Chemistry|December 1, 2009
Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controlsMario Thevis, Ines Möller, Andreas Thomas, et al.
European Journal of Mass Spectrometry (Chichester, England)|July 16, 2016
Identification of selected in vitro generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposesAndreas Lagojda, Dirk Kuehne, Oliver Krug, et al.
Analytical and Bioanalytical Chemistry|August 7, 2012
Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometryCornelius Hess, Andreas Thomas, Mario Thevis, et al.
Drug Testing and Analysis|October 11, 2012
Influence of repeated subcutaneous G-CSF injections on selected blood parameters relevant for monitoring programmes in sports drug testingKatja Walpurgis, Mirjana Slijepcevic, Folker Wenzel, et al.
Rapid Communications in Mass Spectrometry : RCM|February 28, 2014
Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysisMario Thevis, Gerd Sigmund, Andreas Thomas, et al.
Analytical and Bioanalytical Chemistry|February 8, 2011
Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometryAndreas Thomas, Sebastian Höppner, Hans Geyer, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 10, 2014
Use of dried blood spots in doping control analysis of anabolic steroid estersLaura Tretzel, Andreas Thomas, Hans Geyer, et al.
Pageof 28